People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Avenzo Therapeutics, Inc. | — | Biotechnology | Series D+ | $270.6M | $355.3M | 2022 |
| Tmunity Therapeutics, Inc. | — | Biotechnology | Series C | $175.0M | $3.1B | 2019 |
| XTuit Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $39.5M | $748.7M | 2014 |
Garry Nicholson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Garry Nicholson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Judith Li | 2 | 8 |
| Robert Langer | 1 | 36 |
| Carl Gordon | 1 | 24 |
| Beth Seidenberg | 1 | 15 |
| Sean Parker | 1 | 10 |
| Patrick Gray | 1 | 10 |
| Alan Crane | 1 | 9 |
| David Mott | 1 | 9 |
| Simeon George | 1 | 8 |
| Yan Zhang | 1 | 4 |
| Patrick Machado | 1 | 3 |
| Kevin Mahoney | 1 | 3 |
| Edward Freedman | 1 | 3 |
| Michael Rome | 1 | 3 |
| Mohammad Hirmand | 1 | 2 |
| Rakesh Jain | 1 | 2 |
| Athena Countouriotis | 1 | 2 |
| ALESSANDRO RIVA | 1 | 1 |
| Brian Sun | 1 | 1 |
| Jakob Dupont, M.D., M.A. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.